Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,665 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An atypical presentation of a severe and massive atheroembolic disease.
Falcão LP, Fernandes S, Costa AC, Teixeira C, Raimundo M, Silva S, Miranda M, Almeida E. Falcão LP, et al. Among authors: fernandes s. J Bras Nefrol. 2019 Jan-Mar;41(1):142-144. doi: 10.1590/2175-8239-JBN-2018-0013. Epub 2018 Aug 20. J Bras Nefrol. 2019. PMID: 30129967 Free PMC article.
Contrast-induced acute kidney injury in acute ischaemic stroke patients.
Brito C, Falcão L, Raimundo M, Fernandes S, Fernandes A, Silva S, Vilela P, Almeida E. Brito C, et al. Among authors: fernandes s, fernandes a. Neuroradiol J. 2020 Dec 7:1971400920977206. doi: 10.1177/1971400920977206. Online ahead of print. Neuroradiol J. 2020. PMID: 33283660
Painful Leg Ulcers in an ESKD Patient.
Fernandes S, Falcão L, Almeida E. Fernandes S, et al. Kidney360. 2022 Apr 27;3(6):1120-1121. doi: 10.34067/KID.0001132022. eCollection 2022 Jun 30. Kidney360. 2022. PMID: 35845338 Free PMC article. No abstract available.
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study.
Ukashi O, Amiot A, Laharie D, Menchén L, Gutiérrez A, Fernandes S, Pessarelli T, Correia F, Gonzalez-Muñoza C, López-Cardona J, Calabrese G, Ferreiro-Iglesias R, Tamir-Degabli N, Dussias NK, Mousa A, Oliveira R, Richard N, Veisman I, Sharif K, Ben-Horin S, Soutullo-Castiñeiras C, Dragoni G, Rotulo S, Favale A, Calméjane L, Bazin T, Elosua A, Lopes S, Felice C, Mauriz V, Rodrigues IC, Jougon J, Botto I, Tavares de Sousa H, Bertani L, Abadía PR, Bernardi A, Zabana Y, Serra-Ruiz X, Viola A, Barreiro-de Acosta M, Yanai H, Armuzzi A, Magro F, Kopylov U. Ukashi O, et al. Among authors: fernandes s. United European Gastroenterol J. 2025 Jan 18. doi: 10.1002/ueg2.12757. Online ahead of print. United European Gastroenterol J. 2025. PMID: 39825768
1,665 results